Prostate Cancer Screening

Ben Obese-Jecty Excerpts
Monday 26th October 2026

(3 days, 15 hours ago)

Westminster Hall
Read Full debate Read Hansard Text Read Debate Ministerial Extracts

Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.

Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.

This information is provided by Parallel Parliament and does not comprise part of the offical record

Ben Obese-Jecty Portrait Ben Obese-Jecty (Huntingdon) (Con)
- Hansard - -

It is a pleasure to serve under your chairship, Dr Murrison. I declare my interest as an officer of the APPG for prostate cancer. Prostate cancer is a subject close to my heart: we all know that it affects black men, middle-aged men and men with a family history of it, and I tick all those boxes.

My father has prostate cancer and is undergoing treatment. I thank all the staff at Kingston hospital for their swift treatment of him, given he was under active surveillance. That is an important point: he got a PSA test, discovered that he had prostate cancer and as a result was placed on active surveillance because he was below the threshold required for treatment. When that active surveillance proved that he needed to be treated, staff were able to act quickly. That has, fundamentally, saved his life. He would not be eligible for the Transform trial, which will now include black men, until 2028. Who knows how far the cancer might have progressed by that point?

I take my health quite seriously and get a PSA test annually. I got my last PSA test last month and thankfully all is okay for me, but regular testing means I can keep track of it and pay attention to it. It is obvious that we need to encourage more men to get themselves tested. There are a lot of middle-aged men in this Chamber and I suspect that not everybody has had a PSA test, or had one recently.

In August, the Department of Health and Social Care withdrew the prostate cancer risk management programme after 24 years. PCRMP provided a dedicated framework for the informed choice model for PSA testing among asymptomatic men. New guidance removes references to men over 50 being considered to be at increased risk. Now that the guidance underpinning the framework has been withdrawn, will the Minister clarify how requests for testing for asymptomatic men will be handled in practice? I would be grateful if she would also clarify the Government’s official position, stated last week at Health parliamentary questions. I would also appreciate her confirmation that should men suspect that they have symptoms they can go to their GP and seek a PSA test for prostate cancer.